Industrial Policy & Trade Monitor· 2663 actions· ✨ 89 recent

China's Ministry of Commerce issued Announcement No. 26 of 2026 on June 24, 2026, establishing a formal reporting and handling system for violations of export controls on strategic minerals and dual-use items, effective July 1, 2026. The mechanism opens two reporting channels — a dedicated hotline (010-12369) and an online portal (aqygzj.mofcom.gov.cn) — through which any organisation or individual may report suspected violations including unauthorised exports, circumvention via third-country re-routing, illegal technology transfers, and provision of services to sanctioned exporters. Anonymous reports are accepted; real-name reporters may qualify for monetary rewards; voluntary self-disclosure is treated as a mitigating factor in penalty determination. Service providers including freight forwarders and financial institutions face mandatory reporting obligations when they discover suspected violations in the course of business.

China's State Council signed Order No. 837 on May 5, 2026, publishing the Regulations on Outbound Investment by Enterprises on June 1, 2026, effective July 1, 2026. The 34-article framework introduces full-process supervision of all outbound direct investment (ODI) by Chinese enterprises and individuals, requiring combined MOFCOM and export-control clearance for projects involving controlled technologies. The regulations authorise countermeasures against foreign governments that discriminate against Chinese outbound investors and establish a national ODI information-reporting system with real-time monitoring.

On 8 May 2026 China's National Health Commission released a public consultation draft proposing material amendments to the 2023 Implementation Rules for the Administrative Regulations on Human Genetic Resources, with a comment deadline of 7 June 2026. The draft narrows the statutory "foreign party" definition to a bright-line 50% equity/voting threshold (excluding VIE-structured entities), restricts "HGR Information" strictly to nucleic-acid sequence data (excluding clinical, imaging, and metabolic data), removes the separate Article 37 security-review requirement for sensitive HGR datasets, and introduces a same-day or next-working-day fast-track confirmation for international clinical trials not involving HGR information export.

China's Ministry of Industry and Information Technology (MIIT) Raw Materials Industry Division opened a 30-day public consultation on 28 April 2026 on the Administrative Penalty Discretion Standards Table operationalising the State Council's Rare Earth Management Regulation (Order No. 785, in force 1 October 2024). The draft sets a tiered fines schedule for breaches across the entire mining → smelting → separation → sales value chain — fines up to five times "illegal gains" for production-quota breaches under 10%, escalating to product/equipment confiscation and licence revocation for breaches over 30%. Traceability-reporting failures under MIIT's national rare-earth traceability platform are penalised separately with fines up to ten times illegal gains. Comments close 28 May 2026.

Premier Li Qiang signed State Council Order No. 835 on 13 April 2026 promulgating the "Regulations of the People's Republic of China on Countering Foreign States' Unlawful Extraterritorial Jurisdiction" (20 articles), effective on the date of publication. The Regulations are the first State Council–level administrative regulation to operationalise the PRC's framework for identifying and countering foreign extraterritorial measures on a horizontal basis, complementing the 2021 Anti-Foreign Sanctions Law and the March 2025 AFSL implementation regulations. Article 5 establishes a State Council–led inter-agency coordination mechanism; Article 6 vests the State Council legal affairs department (the Ministry of Justice in practice) with authority to identify "improper" foreign extraterritorial measures and to grant exemptions; Article 8 authorises a new Malicious Entity List targeting foreign organisations and individuals that "promote or participate in implementing" such measures, with nine countermeasure categories spanning visa denial, asset freezing, trade restrictions and fines; Article 11 codifies an exemption-application channel under which Chinese persons facing conflicting legal demands may request approval to comply with foreign measures within a defined scope; Article 14 authorises a private right of action for harmed Chinese citizens and organisations to sue parties enforcing such measures; and Article 18 elevates enforcement beyond administrative penalties by referencing potential criminal liability.

The Beijing Economic-Technological Development Zone (BDA / Yizhuang) Management Committee issued "Several Measures on Accelerating Brain-Computer Interface Technology and Industry Innovation Development" (Jingjiguanfa [2026] No. 2), announced 2026-02-04 and effective 2026-02-06 through 2028-12-31. The package comprises 15 initiatives across three pillars — technology/product development, innovation platform construction, and industrial ecosystem building — aimed at moving the BCI sector from research toward clinical translation and commercialization, positioning Yizhuang as a leading domestic and internationally recognized BCI technology and industry hub. It applies to entities legally operating in Yizhuang New City engaged in BCI R&D, product manufacturing, or platform services. No specific monetary figures are disclosed in the published policy interpretation.

On 26 January 2026 Beijing's Dongcheng District (via the Zhongguancun Science Park Dongcheng Zone Management Committee and the district Science and Technology Commission) issued Notice 东城园文〔2026〕2号, "Several Measures of Beijing Dongcheng District on Promoting High-Quality Development of the Pharmaceutical and Health Industry," effective 25 February 2026. The 14-article package spans seven chapters covering traditional-Chinese-medicine industry development, product-innovation value realisation, digital medical services, innovative-medicine support, and talent services, with cash grants of up to RMB 20 million per project and up to RMB 10 million per year for a single market entity in the medical-device segment. A draft version was open for public comment from 18 December 2025 to 17 January 2026 before formal issuance.

China's Ministry of Finance, NDRC, People's Bank of China and National Financial Regulatory Administration jointly issued Cai Jin [2026] No. 2 on 2026-01-19, optimizing the central-fiscal interest-subsidy policy for equipment-renewal loans. The central government subsidizes 1.5 percentage points of loan principal interest on qualifying fixed-asset loans for equipment-renewal projects, capped at two years, and widens eligible sectors beyond traditional industrial/energy/transport/logistics categories to include construction, AI equipment, aerospace materials, agricultural facilities, cold-chain infrastructure and elderly-care equipment. It also folds bank-originated science-and-technology-innovation loans issued from 2026 (previously supported only via PBOC relending) into the fiscal interest-subsidy scope, and simplifies disbursement via a "pre-disbursement + settlement" mechanism across 26 participating banks. The policy runs through 2026-12-31, extendable.

China's Ministry of Finance, NDRC, Ministry of Industry and Information Technology, People's Bank of China and National Financial Regulatory Administration jointly issued Cai Jin [2026] No. 4 on 2026-01-19, establishing a central-fiscal loan interest-subsidy scheme for micro, small and medium-sized enterprises (MSMEs) operating in 14 designated industrial-chain and emerging-industry sectors. Eligible loans originated from 2026-01-01 receive a 1.5-percentage-point annual interest subsidy for up to two years, capped at RMB 50 million in principal per enterprise (maximum subsidy RMB 1.5 million per enterprise). The policy is tentatively set to run one year with a possible extension.

On 2026-01-15 the People's Bank of China announced a CNY 400 billion increase to its science-and-technology-innovation and equipment-renewal relending facility (科技创新和技术改造再贷款), raising the total quota from CNY 800 billion to CNY 1.2 trillion. The measure supports the optimized implementation of the "two new" (equipment renewal / consumer trade-in) policy programme, and from 2026 extends eligibility to private small and medium-sized enterprises with relatively high R&D spending, which were previously excluded from this relending window.

Beijing's Development and Reform Commission, jointly with the municipal Economic and Information Technology Bureau, Science and Technology Commission, and the Zhongguancun Science Park Administration Committee, issued Notice 京发改规〔2026〕1号 on 4 January 2026 setting out measures to expand the city's pilot-testing (中试, "chung-shi"/pilot production and scale-up) service capacity. The policy funds construction and upgrading of pilot-testing platforms that bridge lab-stage R&D and commercial production across AI, biomedicine, green energy, robotics and semiconductors, with a goal of 10 national-level and 50 municipal-level platforms by 2030. Global Trade Alert logged the same underlying state act as five separate interventions (152197-152201) split by affected-country and sector groupings; this filing consolidates them into a single action since they share one primary source document.

Shandong Province's provincial government General Office issued Notice 鲁政办字〔2025〕183号 on 26 December 2025 ("Notice on Several Measures for Fiscal Support of the Integrated Development of Education, Science and Technology, and Talent"), a package of 30 fiscal-support measures running through end-2028. The measures fund R&D grants (up to RMB 30 million for major academician-led projects), talent awards (up to RMB 5 million per person), university-enterprise collaboration funding (up to RMB 15 million/project), an R&D-spend rebate (up to RMB 5 million/year per firm), and a 40%-of-interest subsidy (capped at RMB 500,000 per loan) for bank loans financing technology-achievement commercialization, plus co-financed non-performing-loan risk compensation of up to 90% on those loans. Global Trade Alert logged the interest-payment-subsidy component as a separate intervention tagged with generic extractive-sector codes (coal, crude petroleum, uranium) that do not correspond to any sector language in the underlying notice — the actual measures are horizontal, applying across education, R&D and technology-commercialization activity rather than to any named industry.

On 25 December 2025 Shanghai's Huangpu District Science and Technology Commission and Investment Promotion Office jointly issued Huangkeweigui [2025] No. 3, "Several Measures of Huangpu District on Promoting Brain-Computer Interface Innovation and Transformation Services (Trial)" (informally the "BCI Service 10 Provisions"), effective 24 January 2026 and valid through 31 December 2027. The measures subsidize BCI core- technology R&D and district co-funding of national/municipal projects (up to CNY 2m, 1:1 district match), shared innovation-platform construction (up to 30% of investment, capped CNY 2m), registered medical-device commercialisation (up to 40% of R&D cost, capped CNY 5m/ year per entity), application-demonstration scenarios (up to 30% of investment, capped CNY 2m), enterprise-growth and unicorn/gazelle recognition rewards (CNY 20k-100k), industrial-park operator support (up to CNY 2m/year), equity-financing support (up to 10% of R&D cost, capped CNY 2m, for firms with ≥CNY 20m in equity funding), and international BCI conference/event sponsorship (up to 30%, capped CNY 500k).

On 25 December 2025 Shanghai's Huangpu District Science and Technology Commission and Investment Promotion Office jointly issued Huangkeweigui [2025] No. 2, "Several Measures on Focusing on Translational Medicine to Accelerate Industry-Medicine Integration Innovation and Development," effective 30 days after promulgation (4 February 2026 per Global Trade Alert tracking) and valid through 31 December 2027. The measures subsidize cell-and-gene therapy, mRNA, synthetic biology, regenerative medicine and digital-medicine R&D (up to CNY 2m/year per entity), platform/lab construction (up to 30% of investment, capped at CNY 2m), use of the district's translational-medicine national science facility (up to 50% of annual usage fee, capped at CNY 1m), and domestic Class 1 new-drug clinical trials (Phase I up to CNY 2m, Phase II up to CNY 5m, capped at CNY 50m/year per entity), plus annual support for biopharma industrial- park operators (up to CNY 2m/year).

The Beijing Economic-Technological Development Area (BDA, also known as Yizhuang) Management Committee issued Notice 京技管发〔2025〕33号 on 9 December 2025 ("Several Measures to Accelerate the Cultivation of the Future Energy Industry"), effective through 31 December 2028. The package subsidises R&D, shared technology platforms, industrialisation projects and demonstration deployment across new-type energy storage (solid-state batteries, supercapacitors, flow batteries), clean-energy generation (advanced wind, perovskite solar, hydrogen production/storage), low-carbon transition tech (CCUS, smart grid control) and fusion energy (magnetic and inertial confinement). R&D support runs up to 30% of annual enterprise R&D spend; demonstration-scenario procurement is subsidised up to 30% of cost capped at RMB 500,000 per project; first-of-kind product recognition pays up to RMB 150,000 per project per year. Global Trade Alert logged the underlying state act (95719) as a single "state aid, unspecified" intervention (151443).

The Beijing Economic-Technological Development Area (BDA, also known as Yizhuang) Management Committee issued Notice 京开管发〔2025〕32号 on 10 December 2025 ("Measures for Accelerating the Building of Beijing Yizhuang Automotive Smart Manufacturing Innovation City"), effective through 31 December 2028. The package sets out ten support measures spanning whole-vehicle/component-supplier cooperation, smart-manufacturing upgrades, core-technology R&D, innovation-incubation platforms, new application scenarios, financial support, industrial-ecosystem integration, and vehicle-city fusion development, aimed at building a Beijing-Tianjin-Hebei intelligent-connected new-energy-vehicle advanced manufacturing cluster anchored in Yizhuang. No aggregate budget or per-project subsidy caps are disclosed in the published measures or interpretation notice. Global Trade Alert logged the underlying state act (95714) as a single "state aid, unspecified" intervention (151434).

The Chongqing Municipal Government General Office issued Notice 渝府办发〔2025〕59号 on 2025-12-06, promulgating an "Implementation Plan for Strengthening Fiscal-Financial Linkage to Support High-Quality Economic Development." The plan builds a three-tier (municipal-district-enterprise) government financing-guarantee system, capping average guarantee fees below 1% and prioritising small/micro enterprises and "three-rural" (agriculture, rural areas, farmers) borrowers. It layers in specialised guarantee products across five priority financial verticals: science and technology innovation (innovation-point loans, flow loans, linked loans), green finance (carbon-reduction and transition loans), inclusive finance (emergency bridge loans, government-procurement financing), elder-care services, and manufacturing (technology- renovation guarantees, supply-chain finance products).

On 24 November 2025, six Beijing municipal departments — the Bureau of Economy and Information Technology, Development and Reform Commission, Science and Technology Commission, Health Commission, Drug Administration and Medical Insurance Bureau — jointly issued Notice 京经信发〔2025〕50号 ("Several Measures to Promote High-Quality Development of the Beijing Medical Device Industry"), effective immediately through 31 December 2028. The 15-measure package subsidises the full medical-device value chain: early-stage innovation (up to RMB 1m per project), product approval/launch (up to RMB 2m per product, RMB 10m annual enterprise cap), industrial-park and public-service infrastructure construction (up to 50% of investment, capped at RMB 50m), supply-chain-resilience R&D for critical components/materials (up to 30% of investment, capped at RMB 30m), AI-diagnostic-model development (up to RMB 30m), smart-factory digitalisation (up to 30% of investment, capped at RMB 30m per project), and international regulatory approval/market entry (up to RMB 1m per product, RMB 3m annual cap; up to RMB 10m for introducing overseas products to China).

On 12 November 2025 Beijing's Dongcheng District (via the Zhongguancun Science Park Dongcheng Zone Management Committee and the district Science and Technology Commission) issued Notice 东城园文〔2025〕12号, "Several Measures of Beijing Dongcheng District on Promoting Science and Technology Innovation Development," effective 12 December 2025 through 31 December 2028. The package tiers cash grants by milestone: up to RMB 100,000 for first-time high-tech-enterprise certification, RMB 1 million for first-to-market new technology/products, RMB 10 million for incubator and specialised industrial-park upgrades, and up to RMB 30 million for "chain-leader" enterprises or innovation-driving market entities judged to have significant regional radiating/spillover effect. Eligible sectors span new-generation information technology, cultural technology, pharmaceuticals and health, intelligent manufacturing, new materials, and green energy/environmental protection.

The Chongqing Municipal People's Government General Office issued "Several Measures for Chongqing's Full-Chain Support of High-Quality Innovative Drug Development" (Yu Fu Ban Fa [2025] No. 56) on 2025-11-01, a 25-point package of regulatory-fast-track and procurement-support measures for the municipal biopharma sector. It targets 1-3 newly approved innovative drugs per year through 2027 (10 total) and the cultivation of 3 pharmaceutical-innovation industrial complexes, 3 high-level innovation platforms, and 3 innovative-drug industry clusters. No direct subsidy or tax-incentive amount is disclosed in the published text — the package is operational (compressed clinical-trial and registration timelines, guaranteed hospital procurement) rather than a cash grant.

The Beijing Fengtai District Science and Technology and Information Bureau issued Fengkexinfa [2025] No. 7, "Several Measures to Support AI Science and Technology Innovation and Industrial Innovation Integration and Development in Fengtai District," on 2025-10-30. The notice bundles ten categories of subsidy for AI enterprises operating in the district, covering compute-purchase cost-sharing (20% up to RMB 2,000,000 for general AI firms, 30% up to RMB 3,000,000 for "industrial intelligence" firms), large-model development grants (up to RMB 500,000-600,000), dataset/data-asset subsidies (RMB 100,000-2,000,000), platform and incubator capex (up to RMB 5,000,000 and RMB 10,000,000 respectively), and fund-manager and talent-recruitment support. The measure is in force through 2028-12-31.

The Beijing Municipal Science and Technology Commission and the Zhongguancun Science Park Management Committee, jointly with two other municipal departments, issued "Several Measures on Supporting the Construction of the Beijing Future Digital Space Innovation Pilot Zone" on 2025-10-23 (publicly posted 2025-10-27). The "2+3+5" package of ten measures subsidizes frontier-technology demonstration scenarios (up to 30% of certified investment, capped at RMB 10,000,000), original game and digital-content production (RMB 300,000-2,000,000 per award-winning title), key laboratories (up to RMB 5,000,000/year operating funds plus rent discounts on up to 4,000 sqm, for up to 3 years), industry-chain innovation consortia (up to RMB 20,000,000/year, RMB 50,000,000 over 3 years), and incubators (up to RMB 20,000,000 over 3 years), alongside seed/angel/Series-A co-investment minimums via an industry fund. The pilot zone is anchored on the former Shougang steelworks north campus (core area) and the Jin'anqiao AI large-model industry cluster (innovation-coordination area), both in Beijing's Shijingshan district.

Five Tianhe District (Guangzhou) government bureaus jointly issued Notice 穗天发改规字〔2025〕3号 on 2025-10-16, promulgating "Several Policy Measures to Accelerate High-Quality Development of the Low-Altitude Economy and Aerospace in Tianhe District," effective 30 days after publication (2025-11-19) through 2027-12-31. The package caps district-scale subsidy tracks covering industrial-park and professional-building recognition (up to RMB 1 million per operator), core-technology R&D grants (up to RMB 1 million/year, scaled by enterprise revenue band), airworthiness-certification support (up to RMB 2 million per enterprise/year), low-altitude logistics and eVTOL route operating subsidies (up to RMB 3 million annual pools each), talent incentives (RMB 100,000/person/year, capped at a RMB 10 million pool), vocational training, and insurance support. Global Trade Alert classifies the measure as state aid with a "certainly harmful" (Red) rating.

China's State Council promulgated Order No. 818 on 28 September 2025 (effective 1 May 2026), establishing a comprehensive dual-track regulatory framework for biomedical new technologies — defined as techniques operating at the cellular or molecular level not yet clinically applied in China, covering cell therapy, gene editing, CAR-T, stem-cell, xenotransplantation, brain-computer interfaces, and nucleic-acid therapies. The regulation creates two parallel pathways: a traditional NMPA drug/device registration route and a new NHC-supervised clinical-research-to-commercialization track applicable to highly personalised or rare-disease therapies meeting staged safety and efficacy thresholds. Commercialisation under the NHC track is initially restricted to accredited Grade-3A medical institutions without full NMPA marketing approval, potentially accelerating patient access for qualifying technologies by 5–8 years relative to the standard registration pathway.

China's Ministry of Commerce, Ministry of Industry and Information Technology, General Administration of Customs, and State Administration for Market Regulation jointly issued Announcement No. 54 of 2025 on 26 September 2025, imposing export licence management on pure electric passenger vehicles (HS 8703801090, motor vehicles equipped solely with an electric drive motor and bearing a VIN), effective 1 January 2026. Only vehicle manufacturers and their authorised distributors may apply, and only for their own-brand output; eligibility criteria require Category I exporters to maintain more than 50 overseas after-sales service and maintenance outlets, a minimum 20% spare-parts inventory rate, and a maximum 48-hour maintenance response time in major export markets. The measure is framed by Beijing as shifting the NEV export sector "from scale expansion to quality first" and curbing non-compliant, low-accountability export practices.

On 17 September 2025 the General Office of the Shanghai Municipal People's Government issued Hufubangui [2025] No. 8, a five-year (26 September 2025 - 25 September 2030) state-aid framework to accelerate frontier-technology innovation and cultivate "future industries" across six domains — future manufacturing, future information, future materials, future energy, future space and future health. Targeted technology areas include cell and gene therapy, brain-computer interfaces, biomanufacturing, embodied intelligence (humanoid robotics/AI hardware), fourth-generation semiconductors, silicon photonics, 6G, neuromorphic computing, quantum technology, controlled nuclear fusion and regenerative medicine. Support is disbursed as tiered direct subsidies rather than tax relief, with named ceilings up to CNY 30 million per proof-of-concept/R&D platform and CNY 20 million per high-quality incubator or first-product/batch innovation award.

On 3 September 2025 the Qianhai Authority (前海管理局) issued 深前海规〔2025〕4号, "Measures to Support R&D Centre Development (Trial)", effective 13 September 2025, the first Shenzhen-district-level policy dedicated specifically to R&D centres. Qualifying R&D centres receive a one-time R&D reserve-fund grant of up to RMB 2 million (paid 40/30/30% over three years), with multinational global R&D centres eligible for an additional RMB 6 million. Centres also receive rent relief on Qianhai office space (up to two years free for MNC global R&D centres), a subsidy of up to RMB 3 million/year (20% of qualifying R&D spend), a reduced 15% corporate income tax rate, and technology-breakthrough project grants of up to RMB 30 million (open-competition projects) or RMB 100 million (feasibility-study projects) via Shenzhen's municipal key-industry R&D programme. Distinct from the broader Shenzhen Municipal Government FDI-attraction package (深府规〔2025〕10号, effective 2026-01-01, filed separately) — this is a Qianhai free-trade-zone-level scheme targeting R&D centres specifically, issued three months earlier by a different authority.

On 29 August 2025 the Pinggu District (Beijing) Science, Technology and Economic Informatization Bureau issued "Several Measures to Promote the High-Quality Development of High-End Manufacturing in Pinggu District" (平谷区促进高端制造业高质量发展若干措施), published to the district government portal on 25 September 2025 with a two-year validity period. The scheme offers manufacturers registered and operating in Pinggu a stack of output-growth, R&D, smart-factory, green-transformation, pharma/medical- device, auto-parts-supply-chain, and synthetic-biology subsidies, with per-recipient caps ranging from RMB 200,000 up to RMB 10 million for qualifying pharmaceutical/medical-device innovators.

The Hainan Provincial People's Government General Office issued "Several Policy Measures of Hainan Province for Further Supporting High-Quality Development of the Biopharmaceutical Industry" (Qiong Fu Ban [2025] No. 38) on 2025-08-14, effective 2025-09-13 for a three-year term. The package disburses provincial subsidies across the full biopharma value chain — R&D-stage grants, national centralized-procurement awards, international-certification bonuses, platform-investment reimbursement, and traditional-Chinese-medicine insurance-listing awards — leveraging Hainan Free Trade Port status to build a regional biomedical industry cluster.

The Henan Provincial People's Government issued "Several Policy Measures to Support Enterprise Science and Technology Innovation" (河南省支持企业 科技创新若干政策措施) on 2025-08-08, effective immediately. The package runs a province-wide "unveil-and-lead" (揭榜挂帅) mechanism publishing 100+ key-technology tender projects per year, targeting 200+ core-technology breakthroughs across priority industrial chains, with per-project support of no less than RMB 10 million. It also commits to RMB 160 billion (approx. USD 22 billion) in new 2025 lending to technology enterprises via the province's manufacturing mid/long-term loan pipeline mechanism.

The Henan Provincial People's Government issued "Several Policy Measures to Support the Development of the AI Industry Ecosystem" (河南省支持人工智能 产业生态发展若干政策措施, Yuzheng [2025] No. 17) on 2025-08-04, effective for three years from issuance. The package establishes a RMB 3 billion (approx. USD 420 million) AI industry investment fund alongside a suite of per-project subsidies: up to RMB 1 million for enterprises passing national generative-AI model filing, an annual RMB 50 million compute-voucher pool (capped at RMB 1 million per recipient), up to RMB 1 million per high-quality training-corpus library, and RMB 2-10 million grants for benchmark application projects, industry-empowerment centres and national-level innovation platforms.

On 28 July 2025 the General Office of the Shanghai Municipal People's Government issued Hufubangui [2025] No. 6, the "Shanghai Embodied Intelligence Industry Development Implementation Plan" (上海市具身智能产业发展实施方案), a dedicated municipal state-aid package to build Shanghai into a global innovation hub for embodied intelligence (humanoid robotics / physical AI). The plan targets an industry scale of CNY 500 billion by 2027, alongside at least 20 core algorithm/technology breakthroughs, four or more high-quality incubators, and "100-100-100" targets for leading enterprises, applications and products. Support is disbursed as tiered direct subsidies capped at CNY 50 million (30% of project cost) for core-technology R&D, CNY 40 million per company per year for computing-power credits, CNY 20 million (50% of cost) for public-platform construction, CNY 10 million (20% of cost) for application-demonstration projects, CNY 5 million per company per year for language-corpus services, CNY 5 million (5% of contract value) for robot sales/rental incentives, CNY 5 million per open-source project, and CNY 1 million per leading enterprise for standards development. Target application sectors are logistics, industrial manufacturing, retail, healthcare/eldercare and domestic services.

China's Ministry of Commerce (MOFCOM) and Ministry of Science and Technology (MOST) jointly issued Announcement No. 28 of 2025 on 15 July 2025, partially adjusting the "Catalogue of Technologies Prohibited or Restricted from Export" first published under Announcement No. 57 of 2023. The revision adds new restricted-export entries covering LFP/LMFP cathode electrode material preparation technology, lithium carbonate/lithium hydroxide preparation technology, and gallium processing technology, extending Beijing's export-control perimeter from raw critical minerals into upstream battery-material process technology. The same revision removed three unrelated entries (traditional Chinese architectural technology and building environment-control technology) from the prohibited/restricted lists. The catalogue took effect immediately upon publication and followed a January 2025 public-consultation draft.

The Beijing Economic-Technological Development Zone (BDA / Yizhuang) Management Committee issued Jingjiguanfa [2025] No. 15, "Several Measures on Promoting Quantum Technology and Industry Development in the Beijing Economic-Technological Development Zone," on 2025-07-14, effective immediately and in force through 2027-12-31. The package spans ten support lines covering the full quantum stack (computing hardware/software, communications, sensing): up to RMB 2,000,000 one-off support for disruptive early-stage R&D projects, R&D-investment matching at 20% of an enterprise's prior-year R&D spend capped at RMB 5,000,000, 1:1 matching up to RMB 30,000,000 for enterprises undertaking state/municipal quantum research tasks, RMB 500,000 per product for new-technology/product certifications, up to RMB 100,000 per flagship application-demonstration project, up to RMB 30,000,000/year (three years max) for quantum-computing cloud platforms and compute centers, up to RMB 5,000,000/year (three years max) for operating industry-ecosystem platforms, rent subsidies up to RMB 1.5/sqm/day (max 2,000 sqm, three years), and talent, financing ("patient capital"/future-industry guidance fund), and international- cooperation support. The zone targets an internationally influential quantum industry cluster by 2027.

On 10 July 2025 the Huairou District Economic and Information Technology Bureau (Beijing) issued Huaijingxinfa [2025] No. 35, district-level support measures to promote high-quality development of the advanced manufacturing and software/information-technology services industries, implementing the district's broader high-quality-development guiding opinions (Huaizhengfa [2024] No. 16). The measures cover 13 support categories (R&D, technology upgrading, standards/certification, "specialized, refined, unique and new" (专精特新) enterprise recognition, among others), with individual awards decided case-by-case through an application and government-approval process rather than a disclosed schedule of fixed amounts. A follow-on December 2025 notice solicited enterprise applications for the 2025 award cycle under this same document.

The Beijing Economic-Technological Development Zone (BDA / Yizhuang) Management Committee issued Jingjiguanfa [2025] No. 14, "Several Measures on Accelerating 6G Technology and Industrial Innovation Development in the Beijing Economic-Technological Development Zone," dated 2025-07-08 and effective 2025-07-09. The package funds the 6G stack end to end: up to RMB 5,000,000 start-up funding for provincial/municipal-level 6G laboratories, matching funds up to RMB 30,000,000 for enterprises undertaking national/municipal 6G research tasks, up to RMB 2,000,000 in rewards for accepted 3GPP standard proposals, up to RMB 1,000,000 for standard implementation, up to RMB 30,000,000/year (three-year cap) for test and verification platforms, up to RMB 5,000,000 for "first-order" product support, and testing vouchers of up to RMB 5,000,000 covering 50% of actual testing costs. The zone targets 50+ breakthrough 6G core technologies and standards, 20+ prototype devices, 10+ leading enterprises, 200+ national/municipal high-tech enterprises, and an RMB 50,000,000,000-scale industry cluster by 2030.

Hubei Province established a CNY 10 billion (~USD 1.4 billion) "Hubei Humanoid Robot Industry Investment Mother Fund," led by Changjiang Securities under the province's investment-guidance-fund system. The fund closed partnership registration and a CNY 5 billion first tranche, filed with the Asset Management Association of China, with the Hubei provincial guidance fund and Wuhan Industry Fund each committing 20% and Changjiang Securities and Hubei Science & Technology Investment Group each committing 30%. Capital is earmarked for lead humanoid-robot manufacturers and core-technology suppliers (components, brain-computer interfaces, control systems, model algorithms) as the fund's parent vehicle re-deploys a follow-on tranche via a Wuhan Investment Control Group / East Lake High-Tech Zone cooperation agreement signed 26 July 2025.

On 11 June 2025, at the second Belt and Road Science and Technology Exchange Conference in Chengdu, Sichuan Province formally launched the "Sichuan Sci-Tech Achievement Transformation Investment Guidance Fund" (四川省成果转化投资引导基金) with a total scale of CNY 5 billion (~USD 700 million). The fund is capitalised 40% by the Sichuan Provincial Industrial Investment Guidance Fund, 40% by other in-province state funds, and 20% by capital raised from outside the province. It targets "invest early, invest small, invest in hard tech" bets across seven priority areas — tech/communications, new materials, advanced manufacturing, clean energy, medical and pharmaceutical, energy conservation/environmental protection, and specialised industries — aligned to Sichuan's "15+N" priority industrial-chain plan. Seven sub-funds (one seed-stage, three angel-stage, three venture-stage) totalling CNY 4.05 billion were already established at launch, and the fund's operator (Sichuan Industrial Revitalization Fund Investment Group) stated a 2025 investment target of over CNY 500 million, with CNY 150 million already committed across 4 AI and energy-equipment projects and a further CNY 390 million quasi-approved across 10 projects.

The Shandong Provincial Department of Finance issued Lu Cai Ban Fa [2025] No. 8 (鲁财办发〔2025〕8号), "Several Fiscal Policies to Further Support the High-Quality Development of the Private Economy" (进一步 支持民营经济高质量发展若干财政政策), on 2025-06-09 (published 2025-06-11), effective on issuance through 2027. The package bundles 50 numbered measures across ten categories — technology innovation, digital/smart transformation, industrial upgrading, services, foreign trade, talent attraction, financing channels, government-procurement fairness, overdue-payment relief, and policy-delivery efficiency — targeted at private enterprises operating in Shandong.

China Chengtong Holdings Group, a SASAC-supervised central state capital operation company, completed business registration of the "Chengtong Science and Technology Innovation Investment Fund (Beijing) Limited Partnership" in late May/early June 2025, jointly capitalised with Sinopec, China Aviation Oil, and the Haidian District Government of Beijing. The fund has a total planned scale of CNY 30 billion (~USD 4.2 billion) with a first-phase scale of CNY 10 billion (~USD 1.4 billion) and a 15-year term. It prioritises "early-stage, small-scale, long-term, hard-technology" equity investment across new materials, advanced manufacturing, and next-generation information technology, targeting industry-leading tech firms, "little giant" specialised-and-innovative enterprises, technology-transfer projects, and upstream/downstream suppliers in central-SOE industrial chains.

Shanghai's Development and Reform Commission, Economy and Informatization Commission, and Finance Bureau jointly issued the "Shanghai New-Type Power System Regulation Capacity Incentive Fund Management Measures" (沪发改规范 〔2025〕5号), establishing a five-year per-kilowatt-hour reward scheme for grid-scale energy storage projects that use advanced technology. Independent storage stations meeting technical-advancement and industry-catalysing criteria receive CNY 0.35/kWh (CNY 0.2/kWh for user-side storage), capped at 600 kWh of rewardable output per kW of installed capacity per year for three years, plus a one-time equipment bonus of 40% of the cost premium over conventional lithium-ion storage, capped at CNY 50 million per project. Incentive rates step down 10% annually from 2026-2028. The measure took effect 2025-06-01 and runs for five years.

On 30 April 2025 the General Office of the Guangdong Provincial People's Government issued Yue Fu Ban [2025] No. 11, "Several Measures of Guangdong Province to Further Stimulate Market Entity Vitality and Accelerate the Construction of a Modern Industrial System," effective immediately through 31 December 2027. The package subsidizes bank-loan interest for manufacturing and high-tech enterprises at up to 35% of the loan rate, capped at RMB 2 billion in total annual subsidy volume and RMB 20 million per enterprise per year, alongside an expansion of government-backed financing-guarantee coverage to over RMB 10 billion annually. It also funds foreign-invested R&D centers (up to RMB 1 million, or RMB 5 million for multinational global R&D centers) and offers headquarters-relocation bonuses of up to RMB 8 million, with priority given to semiconductors, AI, robotics, biotechnology, quantum technology, commercial aerospace, and new-energy vehicles.

China's MOFCOM Unreliable Entity List Working Mechanism designated six US firms on 9 April 2025, effective 12:01 Beijing time 10 April 2025, under MOFCOM Order No. 4 of 2020. Cited trigger: participation in arms sales to Taiwan or military-technology cooperation with Taiwan in disregard of China's stated opposition, "seriously harming China's national sovereignty, security and development interests." Measures prohibit the six entities from import/export activities related to China, new investments in China, and impose entry/work-permit restrictions on senior management.

China's MOFCOM Unreliable Entity List Working Mechanism designated 11 US drone-sector companies on 4 April 2025 — Skydio Inc., BRINC Drones Inc., Kratos Unmanned Aerial Systems Inc., Insitu Inc., Red Six Solutions LLC, SYNEXXUS Inc., Firestorm Labs Inc., HavocAI, Neros Technologies, Domo Tactical Communications LLC, and Rapid Flight LLC — citing military-technology cooperation with Taiwan in violation of China's One-China principle. Designations prohibit the 11 firms from import/export activity related to China, bar new investments in China, and restrict senior-executive entry. Issued on the same date as the MOFCOM heavy rare-earth export-licensing measure, the designations formed a paired retaliation package responding to the 2 April 2025 US "Liberation Day" reciprocal-tariff escalation. On 15 May 2025 MOFCOM suspended the UEL restrictions on all 11 companies for 90 days in line with the US-China Geneva tariff truce.

China's Unreliable Entity List (UEL) Working Mechanism, led by MOFCOM, issued Announcement [2025] No. 2 on 4 February 2025, designating PVH Group (parent of Calvin Klein and Tommy Hilfiger) and Illumina Inc. (US genomics / gene-sequencing equipment maker) as Unreliable Entities under the 2020 UEL Provisions, citing violations of normal market-transaction principles and discriminatory measures against Chinese enterprises. PVH was cited for its Xinjiang-cotton sourcing boycott (MOFCOM probe launched September 2024); Illumina was cited for restricting Chinese customers' access to gene-sequencing equipment. The announcement was issued on the same day as China's IEEPA-retaliation tariff package (10–15 % on US coal, LNG, crude oil, agricultural goods, and autos), making it the first UEL listing of a Western consumer-brand / retail company and the first combining a UEL designation with a subsequent sector-specific export prohibition (gene sequencers, imposed 28 February 2025).

China's Unreliable Entity List Working Mechanism, led by MOFCOM, issued Announcement [2025] No. 1 on 2 January 2025 designating 10 US defense entities — five Lockheed Martin subsidiaries (Missiles and Fire Control, Aeronautics, Missile System Integration Lab, Advanced Technology Laboratories, Ventures), the Javelin Joint Venture (Raytheon/Lockheed Martin), Raytheon Missile Systems, and three General Dynamics units (Ordnance and Tactical Systems, Information Technology, Mission Systems) — as Unreliable Entities under the 19 September 2020 Provisions on the Unreliable Entity List, citing their participation in US arms sales to Taiwan. The measures prohibit the 10 firms from engaging in import/export activity related to China and from making new investments in China, and bar approval/renewal of work permits and stay/residence qualifications for their senior executives. This is the first multi-entity UEL designation under the 2020 Provisions and was issued the same day as the parallel MOFCOM Announcement [2025] No. 1 of the export-control bureau adding 28 US entities to China's Export Control List — together establishing a coordinated two-track countermeasure template against US defense and dual-use industry.

China's Ministry of Commerce and General Administration of Customs jointly issued Announcement No. 33 of 2024 on 15 August 2024, imposing an export licensing regime on antimony ore, antimony metal, antimony oxides (purity ≥99.99%), organic antimony compounds, antimony hydride, indium antimonide, and gold-antimony smelting technology, effective 15 September 2024. The announcement also covers six-sided top-press equipment used in superhard-materials (diamond, cubic boron nitride) production. China accounts for approximately 47% of global antimony mine output and an estimated 75-80% of refined antimony supply; in the months following implementation, Chinese antimony export volumes fell by approximately 97% and global antimony trioxide spot prices roughly doubled.

China's State Council Tariff Commission published its annual "2023 Tariff Adjustment Plan" (税委会公告2022年第11号) on 28 December 2022, effective 1 January 2023. Alongside routine import-side changes (provisional-rate cancellations reverting some goods to MFN rates, and an eighth-step MFN cut on 62 information-technology products from 1 July 2023), the plan raises export tariffs on aluminum and aluminum alloy to support "transformation, upgrading and high-quality development" of the domestic industry. Global Trade Alert logs this export-tax increase as the "certainly harmful" intervention within the bundled state act; a separate import-tariff cut is logged as liberalising.

On 15 March 2019, the Second Session of the 13th National People's Congress adopted the Foreign Investment Law of the People's Republic of China (FIL), effective 1 January 2020. The statute replaced the prior tripartite FDI regime — the 1979 Equity Joint Venture Law, the 1986 Wholly Foreign-Owned Enterprise Law, and the 1988 Contractual Joint Venture Law (collectively the "Three Laws") — with a unified legal framework covering all foreign investment in China. The FIL establishes a pre-establishment national treatment plus negative-list regime jointly administered by NDRC and MOFCOM, a Foreign Investment Information Reporting System replacing the former case-by-case approval regime, a national security review mechanism (China's CFIUS equivalent, codified at Art. 35), and Art. 22 technology-transfer prohibition protections. The State Council Implementation Regulations (Order No. 723, promulgated 26 December 2019) entered force on the same date as the FIL.